Table 2.
Baseline demographics of study patients
Characteristic | Control (n=16) | Intervention (n=19) |
---|---|---|
Age (yr), mean (SD) | 68 (14) | 69 (11) |
Sex, n (%) | ||
Female | 8 (50) | 11 (58) |
Male | 8 (50) | 8 (42) |
Race, n (%) | ||
American Indian or Alaska Native | 0 (0.0) | 1 (5) |
Asian | 0 (0.0) | 1 (5) |
Black or African American | 6 (38) | 4 (21) |
White | 10 (63) | 13 (68) |
Ethnicity, n (%) | ||
Hispanic/Latino | 0 (0) | 3 (16) |
Non-Hispanic or Latino | 16 (100) | 16 (84) |
Education, n (%) | ||
Less than high school | 1 (7) | 0 (0) |
High school/GED | 3 (21) | 9 (47) |
College | 5 (36) | 4 (21) |
Graduate/professional degree | 5 (36) | 6 (32) |
Comorbidities, n (%) | ||
Cancer (history of or in remission) | 3 (19) | 1 (5) |
Congestive heart failure | 1 (6) | 0 (0) |
Coronary artery disease | 3 (19) | 2 (11) |
Diabetes | 5 (31) | 10 (53) |
Liver disease | 1 (6) | 0 (0) |
None of the above | 0 (0) | 3 (16) |
Other | 3 (19) | 3 (16) |
Charlson Comorbidity Index, mean (SD) | 6 (2) | 5 (2) |
Karnofsky Performance Score, mean (SD) | 66 (26) | 78 (19) |
GFR (ml/min per 1.73 m2), mean (SD) | 11 (2) | 11 (5) |
Cause of kidney failure, n (%) | ||
Diabetes | 4 (25) | 4 (21) |
Glomerular disease | 2 (13) | 0 (0) |
Hypertension | 5 (31) | 10 (53) |
Other | 5 (31) | 5 (26) |
Albumin (g/dl), mean (SD) | 3.8 (0.40) | 3.9 (0.4) |
Hemoglobin (g/dl), mean (SD) | 9.5 (1.90) | 10.0 (1.6) |
Lives alone, n (%) | 7 (50) | 8 (42) |
Presence of a health care proxy, n (%) | 11 (79) | 11 (58) |
Presence of advance care planning documents, n (%) | 5 (36) | 4 (21) |
GED, General Education Development Test.